Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Case ReportNuclear Oncology

Somatostatin Receptor Expression in Hürthle Cell Cancer of the Thyroid

Seza A. Gulec, Aldo N. Serafini, Kasi S. Sridhar, Kamil R. Peker, Anurag Gupta, W. Jarrard Goodwin, George N. Sfakianakis and Frederick L. Moffat
Journal of Nuclear Medicine February 1998, 39 (2) 243-245;
Seza A. Gulec
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aldo N. Serafini
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kasi S. Sridhar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kamil R. Peker
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anurag Gupta
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
W. Jarrard Goodwin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George N. Sfakianakis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frederick L. Moffat
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading
PDF extract preview

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 39, Issue 2
February 1, 1998
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Somatostatin Receptor Expression in Hürthle Cell Cancer of the Thyroid
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Somatostatin Receptor Expression in Hürthle Cell Cancer of the Thyroid
Seza A. Gulec, Aldo N. Serafini, Kasi S. Sridhar, Kamil R. Peker, Anurag Gupta, W. Jarrard Goodwin, George N. Sfakianakis, Frederick L. Moffat
Journal of Nuclear Medicine Feb 1998, 39 (2) 243-245;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Somatostatin Receptor Expression in Hürthle Cell Cancer of the Thyroid
Seza A. Gulec, Aldo N. Serafini, Kasi S. Sridhar, Kamil R. Peker, Anurag Gupta, W. Jarrard Goodwin, George N. Sfakianakis, Frederick L. Moffat
Journal of Nuclear Medicine Feb 1998, 39 (2) 243-245;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • 68Ga-DOTATOC PET/CT in Patients with Iodine- and 18F-FDG-Negative Differentiated Thyroid Carcinoma and Elevated Serum Thyroglobulin
  • Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors
  • Diagnostic Accuracy and Prognostic Value of 18F-FDG PET in Hurthle Cell Thyroid Cancer Patients
  • Peptide Receptor Imaging and Therapy
  • Google Scholar

More in this TOC Section

  • Flare Response Seen in Therapy for Osteomalacia
  • Dose Escalation Trial of Indium-111-Labeled Anti-Carcinoembryonic Antigen Chimeric Monoclonal Antibody (Chimeric T84.66) in Presurgical Colorectal Cancer Patients
  • Optimized Conditions for Chelation of Yttrium-90-DOTA Immunoconjugates
Show more Nuclear Oncology

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire